Cyclica (acquired by Recursion, Nasdaq: RXRX)’s Post

Cyclica (acquired by Recursion, Nasdaq: RXRX) reposted this

View organization page for Valence Labs, graphic

7,961 followers

Today, we begin our new journey as Valence Labs: a semi-autonomous research engine within Recursion, dedicated to advancing the frontier of deep learning in drug discovery. We’ve got a lot in store. Read on to learn more ⬇️ We are committing up to $1 million to advance the next generation of academic machine learning research and talent through scholarships, fellowships and other talent programs. Learn more about the Valence Scholars program & apply now: https://lnkd.in/eHxRy5zk This is just the beginning. Combining the intellectual freedom of academia with the resources and stability of industry, Valence Labs will take a long-term view on technology development, working at the frontiers of #machinelearning and therapeutic discovery. As we build, we will remain steadfast in our commitment to open-source and open-science. Stay tuned for the release of data, tools and infrastructure in the near future! There is challenging and exciting work to be done, and we hope that you feel inspired to join us in writing this next chapter. Read the full story: https://lnkd.in/evSw8J24 #techbio #artificialintelligence #deeplearning #digitalchemistry #ML #icml2023

Valence Labs | Our Story

Valence Labs | Our Story

valencelabs.com

To view or add a comment, sign in

Explore topics